Abdullah Saad

Dr. Abdullah Saad

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2026 in Nutrition Research
Verified
Journal Article
Closed access
SKSaim Mahmood Khan
Saim Mahmood Khan
JHJawairya Muhammad Hussain
Jawairya Muhammad Hussain
BKBarina Khan
Barina Khan
ASAbdullah Saad
Abdullah Saad
JMJaweria Mehboob
Jaweria Mehboob
RHRida Hashim
Rida Hashim

1 August 2025 in Journal of Geriatric Cardiology
Verified
Journal Article
Open access
PDF file
BKBarina Khan
Barina Khan
ASAbdullah Saad
Abdullah Saad

30 July 2025 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
ASAbdullah Saad
Abdullah Saad

30 April 2026 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
AAAleeza Abid
Aleeza Abid
MNMubashira Noor
Mubashira Noor
ASAbdullah Saad
Abdullah Saad
SFSolay Farhat
Solay Farhat
NSNazish Sikander
Nazish Sikander
TATanveer Ahmad
Tanveer Ahmad
Introduction and importance: Primary osteosarcoma of the sternum is a rare malignant bone tumor. Only a few cases have been documented, and most have been managed with chemotherapy and surgical intervention. Our case is distinctive due to the vascular invasion of the left brachiocephalic vein and lack of response to chemotherapy. Reporting this case contributes to the limited literature and highlights the diagnostic and therapeutic challenges associated with the management of primary sternal osteosarcoma. Case presentation: We describe a 37-year-old woman with a painful, progressively enlarging manubrial swelling. Imaging revealed a destructive sternal mass with mediastinal extension, pulmonary and nodal metastases, and a thrombus extending from the left brachiocephalic vein to the superior vena cava. Magnetic resonance imaging confirmed soft tissue infiltration, cardiac compression, and worsening pericardial effusion. Biopsy revealed malignant osteoid-forming cells with SATB2 positivity, confirming the diagnosis of primary sternal osteosarcoma. She received three cycles of doxorubicin and cisplatin, but her condition rapidly progressed. Regorafenib was initiated as salvage therapy; however, her condition worsened, and she died within 6 months of diagnosis. Clinical discussion: Primary osteosarcoma of the sternum is a rare and aggressive malignancy in adults. Imaging is crucial for staging and planning surgery. Standard treatment includes neoadjuvant chemotherapy with wide excision and reconstruction, whereas targeted therapies such as regorafenib may be considered for metastatic diseases. Conclusion: This case illustrates an exceptionally aggressive tumor complicated by vascular invasion and mediastinal involvement. This underscores the importance of early recognition to avoid diagnostic delays and demonstrates the limited efficacy of conventional chemotherapy in advanced disease. The use of regorafenib highlights the emerging systemic options that may be explored in refractory osteosarcoma. Our report emphasizes the urgent need for early diagnostic practices and a multidisciplinary approach to treatment.

20 February 2025 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
ASAbdullah Saad
Abdullah Saad
DSDua Fatima Sherwani
Dua Fatima Sherwani
Doi: https://doi.org/10.12669/pjms.41.3.11949 How to cite this: Saad A, Sherwani DF. Critical analysis of maternal healthcare delivery systems and mortality patterns: A commentary on research from a tertiary care center in Pakistan. Pak J Med Sci. 2025;41(3):-939. doi: https://doi.org/10.12669/pjms.41.3.11949

9 July 2026 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
ASAbdullah Saad
Abdullah Saad
BKBarina Khan
Barina Khan
ABAhmed Reda Bahr
Ahmed Reda Bahr
MAMostafa Abdelhakiem
Mostafa Abdelhakiem